These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 37346068)
1. Development of a prognostic model based on ferroptosis-related genes for colorectal cancer patients and exploration of the biological functions of NOS2 Li H; Feng X; Hu Y; Wang J; Huang C; Yao X Front Oncol; 2023; 13():1133946. PubMed ID: 37346068 [TBL] [Abstract][Full Text] [Related]
2. Prognostic and Predictive Models for Left- and Right- Colorectal Cancer Patients: A Bioinformatics Analysis Based on Ferroptosis-Related Genes. Chen Y; Li H Front Oncol; 2022; 12():833834. PubMed ID: 35265525 [TBL] [Abstract][Full Text] [Related]
3. Identification of a Novel Ferroptosis-Related Gene Prediction Model for Clinical Prognosis and Immunotherapy of Colorectal Cancer. Yang YB; Zhou JX; Qiu SH; He JS; Pan JH; Pan YL Dis Markers; 2021; 2021():4846683. PubMed ID: 34868393 [TBL] [Abstract][Full Text] [Related]
4. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer. Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989 [TBL] [Abstract][Full Text] [Related]
5. A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer. Yang L; Li C; Qin Y; Zhang G; Zhao B; Wang Z; Huang Y; Yang Y Front Oncol; 2021; 11():686044. PubMed ID: 34422642 [TBL] [Abstract][Full Text] [Related]
6. Identification and validation of ferroptosis-related prognostic gene signature in patients with cervical cancer. Ruan XF; Wen DT; Xu Z; Du TT; Fan ZF; Zhu FF; Xiao J Transl Cancer Res; 2024 Jul; 13(7):3382-3396. PubMed ID: 39145078 [TBL] [Abstract][Full Text] [Related]
7. Ferroptosis-related genes are potential prognostic molecular markers for patients with colorectal cancer. Liu Y; Guo F; Guo W; Wang Y; Song W; Fu T Clin Exp Med; 2021 Aug; 21(3):467-477. PubMed ID: 33674956 [TBL] [Abstract][Full Text] [Related]
8. Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer. Sun J; Yue W; You J; Wei X; Huang Y; Ling Z; Hou J Front Oncol; 2021; 11():730716. PubMed ID: 34557413 [TBL] [Abstract][Full Text] [Related]
9. Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients. Du S; Zeng F; Sun H; Liu Y; Han P; Zhang B; Xue W; Deng G; Yin M; Cui B Bioengineered; 2022 Feb; 13(2):2498-2512. PubMed ID: 35067161 [TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma. Miao YD; Kou ZY; Wang JT; Mi DH World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046 [TBL] [Abstract][Full Text] [Related]
11. An Original Ferroptosis-Related Gene Signature Effectively Predicts the Prognosis and Clinical Status for Colorectal Cancer Patients. Shao Y; Jia H; Huang L; Li S; Wang C; Aikemu B; Yang G; Hong H; Yang X; Zhang S; Sun J; Zheng M Front Oncol; 2021; 11():711776. PubMed ID: 34249766 [TBL] [Abstract][Full Text] [Related]
12. Construction of A Novel Ferroptosis-related Prognostic Risk Signature for Survival Prediction in Clear Cell Renal Cell Carcinoma Patients. Tang F; Zhang J; Zhu L; Lai Y; Li Z; Lu Z; Tang Z; Mai Y; Huang R; He Z Urol J; 2022 May; 19(4):289-299. PubMed ID: 35598038 [TBL] [Abstract][Full Text] [Related]
13. Ferroptosis and cuproptosis prognostic signature for prediction of prognosis, immunotherapy and drug sensitivity in hepatocellular carcinoma: development and validation based on TCGA and ICGC databases. Ma Q; Hui Y; Huang BR; Yang BF; Li JX; Fan TT; Gao XC; Ma DY; Chen WF; Pei ZX Transl Cancer Res; 2023 Jan; 12(1):46-64. PubMed ID: 36760376 [TBL] [Abstract][Full Text] [Related]
14. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma. Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048 [TBL] [Abstract][Full Text] [Related]
15. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma. Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889 [TBL] [Abstract][Full Text] [Related]
16. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes. Diao X; Guo C; Liu L; Wang G; Li S Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420 [TBL] [Abstract][Full Text] [Related]
17. Integrating ferroptosis-related genes (FRGs) and prognostic models to enhance UCEC outcome prediction and therapeutic insights. Jin W; Zhuang X; Lin Y; Zhao X J Appl Genet; 2023 Dec; 64(4):723-735. PubMed ID: 37626211 [TBL] [Abstract][Full Text] [Related]
18. Identification of a ferroptosis-related gene signature (FRGS) for predicting clinical outcome in lung adenocarcinoma. Wang S; Wu C; Ma D; Hu Q PeerJ; 2021; 9():e11233. PubMed ID: 33954048 [TBL] [Abstract][Full Text] [Related]
19. Identification of a Ferroptosis Gene Set That Mediates the Prognosis of Squamous Cell Carcinoma of the Head and Neck. Li C; Wang X; Qin R; Zhong Z; Sun C Front Genet; 2021; 12():698040. PubMed ID: 34539737 [TBL] [Abstract][Full Text] [Related]
20. A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma. Wang X; Meng Y; Liu C; Yang H; Zhou S J Oncol; 2022; 2022():9103259. PubMed ID: 36131791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]